Buyback yield (TTM)
0.26%
Shareholder yield (TTM)
0.26%
5Y share count change
3.8%
Buyback spend (TTM)
$235.68M
Cumulative buybacks
$8.29B
Key takeaways
- Synopsys (SNPS) repurchased about $235.68M of stock over the trailing twelve months.
- Diluted share count is up 3.8% over the last ~5 fiscal years — equity issuance and stock-based compensation are outpacing repurchases.
- TTM buyback ÷ stock-based-comp ratio of 0.24× — repurchases only partially offset SBC dilution.
- Cash buyback spend has compounded at -100.0% per year over the latest 5-year window.
- TTM repurchases used about 9% of free cash flow remaining after dividends.
Dividend & buyback yield over time for Synopsys (SNPS)
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Diluted vs basic shares (annual) for Synopsys (SNPS)
Diluted weighted-average shares are the EPS denominator — a falling count means buybacks are outpacing SBC dilution.
Year-over-year change in diluted shares for Synopsys (SNPS)
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Cash buyback spend over time for Synopsys (SNPS)
Latest: $0.00
Overview
In 2025, Synopsys (SNPS) buyback spend totalled $0.00.
Through 2020–2025 (5 years), Synopsys buyback spend delivered a -100.0% annualised rate; with a net decline across the window.
Synopsys buyback spend peaked at $1.16B in 2023; the latest annual figure is $0.00 in 2025 (100.0% below peak).
2023 marks the peak buyback spend at $1.16B, with the historical low of $0.00 recorded in 1990.
Synopsys Buyback Spend 2025: $0.00
Synopsys buyback spend in 2025 was $0.00.
Synopsys Buyback Spend 2024: $0.00
Synopsys posted buyback spend of $0.00 in 2024, plunged 100.0% below 2023.
Synopsys Buyback Spend 2023: $1.16B
In 2023, Synopsys reported buyback spend of $1.16B, grew 5.5% from 2022. This figure represents the highest annual value in the available history.
Synopsys Buyback Spend 2022: $1.10B
Synopsys buyback spend in 2022 was $1.10B, surged 46.1% from 2021.
Synopsys Buyback Spend 2021: $753.08M
Synopsys buyback spend in 2021 was $753.08M.
See more financial history for Synopsys (SNPS).
Buyback, SBC & dilution history
Buyback spend, SBC, net dilution effect, and share count.
| 2025 | $0.00 | $893.29M | −$893.29M | — | 0.16B | +3.7% | |
| 2024 | $0.00 | $692.32M | −$692.32M | — | 0.16B | +0.5% | |
| 2023 | $1.16B | $563.29M | $597.43M | 1.63% | 0.16B | -0.8% | |
| 2022 | $1.10B | $459.03M | $640.97M | 2.46% | 0.16B | -0.5% | |
| 2021 | $753.08M | $345.27M | $407.81M | 1.49% | 0.16B | +1.0% | |
| 2020 | $242.08M | $248.58M | −$6.51M | 0.74% | 0.16B | +1.0% | |
| 2019 | $329.19M | $155.00M | $174.18M | 1.61% | 0.15B | +0.5% | |
| 2018 | $400.00M | $140.03M | $259.97M | 3.00% | 0.15B | -1.0% | |
| 2017 | $380.00M | $108.29M | $271.71M | 2.93% | 0.15B | +0.1% | |
| 2016 | $400.00M | $97.58M | $302.42M | 4.45% | 0.15B | -2.1% | |
| 2015 | $260.00M | $86.40M | $173.60M | 3.35% | 0.16B | +0.2% | |
| 2014 | $119.75M | $79.44M | $40.31M | 1.87% | 0.16B | +0.7% | |
| 2013 | $145.02M | $67.51M | $77.50M | 2.58% | 0.16B | +4.2% | |
| 2012 | $40.00M | $71.41M | −$31.41M | 0.84% | 0.15B | -0.1% | |
| 2011 | $401.84M | $56.41M | $345.42M | 10.42% | 0.15B | -1.0% | |
| 2010 | $184.70M | $59.99M | $124.71M | 4.90% | 0.15B | +4.2% | |
| 2009 | $0.00 | $56.93M | −$56.93M | — | 0.15B | -1.2% | |
| 2008 | $220.05M | $65.47M | $154.58M | 8.45% | 0.15B | -1.4% | |
| 2007 | $151.62M | $0.00 | $151.62M | 3.73% | 0.15B | +3.4% | |
| 2006 | $199.99M | $0.00 | $199.99M | 6.23% | 0.14B | -0.2% | |
| 2005 | $88.39M | $0.00 | $88.39M | 3.24% | 0.14B | -8.3% | |
| 2004 | $423.30M | $0.00 | $423.30M | 16.54% | 0.16B | -3.9% | |
| 2003 | $260.75M | $0.00 | $260.75M | 5.36% | 0.16B | +24.2% | |
| 2002 | $171.68M | $0.00 | $171.68M | 6.37% | 0.13B | +2.4% | |
| 2001 | $331.88M | $0.00 | $331.88M | 11.76% | 0.13B | -8.9% | |
| 2000 | $397.47M | $0.00 | $397.47M | — | 0.14B | -3.3% | |
| 1999 | $95.40M | $0.00 | $95.40M | — | 0.15B | +5.6% | |
| 1998 | $12.40M | $0.00 | $12.40M | — | 0.14B | +6.0% | |
| 1997 | $9.50M | $0.00 | $9.50M | — | 0.13B | +57.4% | |
| 1996 | $14.80M | $0.00 | $14.80M | — | 0.08B | — | |
| 1995 | $0.00 | $0.00 | $0.00 | — | — | — | |
| 1994 | $0.00 | $0.00 | $0.00 | — | — | — | |
| 1993 | $0.00 | $0.00 | $0.00 | — | — | — | |
| 1992 | $0.00 | $0.00 | $0.00 | — | — | — | |
| 1991 | $0.00 | $0.00 | $0.00 | — | — | — | |
| 1990 | $0.00 | $0.00 | $0.00 | — | — | — |
- 2025$0.00
- 2024$0.00
- 2023$1.16B
- 2022$1.10B
- 2021$753.08M
- 2020$242.08M
- 2019$329.19M
- 2018$400.00M
- 2017$380.00M
- 2016$400.00M
- 2015$260.00M
- 2014$119.75M
- 2013$145.02M
- 2012$40.00M
- 2011$401.84M
- 2010$184.70M
- 2009$0.00
- 2008$220.05M
- 2007$151.62M
- 2006$199.99M
- 2005$88.39M
- 2004$423.30M
- 2003$260.75M
- 2002$171.68M
- 2001$331.88M
- 2000$397.47M
- 1999$95.40M
- 1998$12.40M
- 1997$9.50M
- 1996$14.80M
- 1995$0.00
- 1994$0.00
- 1993$0.00
- 1992$0.00
- 1991$0.00
- 1990$0.00
Buybacks vs stock-based compensation for Synopsys (SNPS)
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 0.24×.
Buybacks vs dividends (share of cash returned) for Synopsys (SNPS)
How Synopsys splits cash returned to shareholders between dividends and buybacks.
Sector peers by buyback spend
Companies in the same sector as Synopsys, ranked by their latest buyback spend.
| $90.71B | |
| $40.09B | |
| $18.42B | |
| $6.65B | |
| $6.31B | |
| $1.32B | |
| $0.00 | |
| $0.00 |
- $90.71B
- $40.09B
- $18.42B
- $6.65B
- $6.31B
- $1.32B
- $0.00
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $2.68B (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Data & methodology
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation